Please assess the completion status of the following clinical trial:

Trial Title: Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Subfertile women aged 35-40 years with repeated implantation failure or recurrent miscarriage with positive natural killer cells undergoing Intracytoplasmic sperm injection (ICSI ) cycle.~Exclusion Criteria:~* women above 40years or less than 35 years~* Disturbances of normal fat metabolism such as pathologic hyperlipidemia,Lipoid nephrosis or acute pancreatitis with hyperlipidemia.~* Allergic to eggs, soybean oil, or safflower oil.~* Severe liver disease, kidney disease, lung disease, anemia, blood coagulation disorder.~* Uterine fibroid, endometrial polyp, endometriosis and hydrosalpinx.~* Antiphospholipid syndrome (lupus anticoagulant and/or anticardiolipin antibodies (Immunoglobulin G or M)\[IgG or IgM\]); other recognised thrombophilic conditions (testing according to usual clinic practice).~* Intrauterine abnormalities (as assessed by ultrasound, hysterosonography, hysterosalpingogram, or hysteroscopy).~* Fibroids distorting uterine cavity.~* Abnormal parental karyotype.

- Gender: FEMALE
- Minimum Age: 35 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Intralipid infusion (Type: ACTIVE_COMPARATOR): 100 Subfertile women aged 35-40 years with repeated implantation failure or recurrent miscarriage with positive natural killer cells undergoing ICSI cycle.
- Control group (Type: NO_INTERVENTION): 100 Subfertile women aged 35-40 years with repeated implantation failure or recurrent miscarriage with positive natural killer cells undergoing ICSI cycle.

Based on this trial design, predict the completion outcome and termination type (if applicable).